Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalizing Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia Using Clinical Biomarkers for MDD Subtypes

NCT05869708 is registered in ClinicalTrials.gov with GrayMatters Health Ltd. as lead sponsor.

NCT NCT05869708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05869708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalizing Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia Using Clinical Biomarkers for MDD Subtypes
Lead sponsor
GrayMatters Health Ltd.
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2023
Completion date
September 3, 2025
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, depression